Specialized Ophthalmology in Seoul · Dedicated International Patient Concierge
MOHW Registered · Foreign Patient Care
en-US
Retina & Glaucoma Treatment · Needs Clinic Confirmation
Diabetic Retinopathy
Diabetic retinopathy is a diabetes-related complication that damages the blood vessels of the retina, and it is one of the leading causes of vision loss among adults with diabetes.
Schedule a ConsultationDiabetic Retinopathy

Medically reviewed by Dr. Kim Yoon Kyung, Director, Ophthalmologist (Master of Medicine), board-certified, Korean Ophthalmological Society
Diabetic retinopathy is a diabetes-related complication that damages the blood vessels of the retina, and it is one of the leading causes of vision loss among adults with diabetes. At Jamsil Samsung Eye Clinic in Songpa-gu, Seoul, diabetic retinopathy is evaluated and managed with the goal of detecting retinal changes early, since timely treatment can help preserve vision that might otherwise be lost as the condition progresses.
What Is Diabetic Retinopathy?
Because diabetic retinopathy can progress with few or no early symptoms, understanding the condition and its risk factors is an important first step for anyone living with diabetes.
Diabetic retinopathy develops when chronically elevated blood sugar damages the small blood vessels supplying the retina, the light-sensitive tissue at the back of the eye.
Damaged retinal blood vessels can swell, leak fluid, or close off entirely; in more advanced stages, the retina may respond by growing abnormal new blood vessels, a stage known as proliferative diabetic retinopathy, which carries a higher risk of severe vision loss.
Diabetic macular edema, a swelling of the macula (the central part of the retina responsible for sharp vision) due to fluid leakage, can occur at any stage of diabetic retinopathy and is a common cause of vision loss in patients with diabetes.
Risk increases with the duration of diabetes, poorly controlled blood sugar, high blood pressure, high cholesterol, and pregnancy; both type 1 and type 2 diabetes carry this risk.
Early-stage diabetic retinopathy often causes no noticeable symptoms, which is why regular dilated eye exams are recommended for people with diabetes regardless of whether their vision currently feels normal.
Symptoms in more advanced stages can include blurred or fluctuating vision, dark spots or floaters, impaired color vision, and, in severe cases, vision loss.
Who Oversees Diabetic Retinopathy Care at Jamsil Samsung Eye Clinic

Dr. Kim Yoon Kyung, a director at Jamsil Samsung Eye Clinic, is a board-certified ophthalmologist who graduated from Soonchunhyang University College of Medicine and earned a Master's degree in ophthalmology from the Graduate School of Soonchunhyang University, completing her ophthalmology specialist training at Soonchunhyang University Hospital. Her academic publications include research on flash electroretinography and visual evoked potentials in diabetic retinopathy patients with vitreous hemorrhage — directly relevant to this condition — alongside work on open-angle glaucoma and retinal degeneration. She is a full member of the Korean Ophthalmological Society, Korean Optometric Association, Korean Contact Lens Society, Korean External Ocular Diseases Society (KEEDS), and Korean Society of Cataract and Refractive Surgery.
Who Should Be Evaluated for Diabetic Retinopathy
Anyone with type 1 or type 2 diabetes, since diabetic retinopathy can develop at any point after diagnosis and often without symptoms in its earlier stages.
Patients with a longer duration of diabetes, poorly controlled blood sugar, high blood pressure, high cholesterol, or who are pregnant, since these factors increase risk.
Patients experiencing blurred or fluctuating vision, new floaters, dark spots, or changes in color vision should be evaluated promptly, particularly if they have a diabetes diagnosis.
Patients already diagnosed with diabetic retinopathy who need ongoing monitoring to track whether the condition is stable, improving, or progressing toward more advanced or vision-threatening stages.
What to Expect: Diagnosis, Treatment, and Results Timeline
Diagnosis typically involves a dilated eye exam to directly examine the retina, optical coherence tomography (OCT) to assess retinal thickness and detect macular edema, and sometimes fluorescein angiography to visualize blood flow and leakage within the retinal vessels. Treatment depends on the stage and severity of disease and can include closer monitoring for early, mild disease; anti-VEGF injections into the eye to reduce abnormal blood vessel growth and macular edema; laser photocoagulation to treat leaking or abnormal vessels; and, in advanced cases with bleeding into the vitreous or retinal detachment risk, vitrectomy surgery. Anesthesia requirements vary by treatment: diagnostic imaging requires none, injections and laser treatment are typically performed with topical or local anesthesia, and vitrectomy surgery may require a more involved anesthesia approach depending on the case.
Diabetic retinopathy management is generally an ongoing process closely tied to overall diabetes control, rather than a single treatment that resolves the condition permanently; blood sugar, blood pressure, and cholesterol management alongside eye-specific treatment all factor into long-term outcomes. Follow-up intervals depend on the stage of disease at diagnosis, ranging from annual dilated exams for patients with no or mild retinopathy to much more frequent monitoring, sometimes monthly, for patients receiving anti-VEGF injections for macular edema or proliferative disease. Preparation for a dilated eye exam is minimal, though patients should expect temporary blurred vision and light sensitivity afterward and should arrange transportation accordingly. Aftercare depends on treatment: patients receiving injections are typically monitored briefly afterward and advised on warning signs of infection or elevated eye pressure, while those undergoing laser treatment or vitrectomy follow their surgeon's specific post-procedure instructions.
International Patient Considerations
International patients with diabetes should treat a comprehensive dilated retinal exam as a standard part of their overall diabetes care, even during a trip focused primarily on other treatment, since diabetic retinopathy can progress silently between visits. Patients already receiving treatment for diabetic retinopathy — particularly ongoing anti-VEGF injections — should understand that this is typically a repeated, scheduled treatment rather than a one-time procedure, and should discuss with the clinic in advance how injection scheduling will be coordinated if their treatment plan calls for injections at intervals that extend beyond a single visit to Seoul. Bringing recent retinal imaging, OCT scans, and details of diabetes control (such as recent HbA1c results) can help the clinic's ophthalmologists assess disease trajectory more accurately at the first visit. Patients with more advanced disease, including proliferative diabetic retinopathy or vitreous hemorrhage, should be prepared for the possibility that treatment may need to be staged across multiple visits or coordinated with a local retina specialist at home for continuity of care.
Safety, Precision, and Clinic Standards
Diagnostic and treatment tools for diabetic retinopathy generally include fundus cameras, OCT scanners, fluorescein angiography equipment, laser photocoagulation systems, and anti-VEGF injection protocols, supported by the clinic's AI-assisted diagnostic evaluation described elsewhere in its retina and glaucoma services. Risks vary by treatment: anti-VEGF injections carry a small risk of infection, elevated eye pressure, or, rarely, more serious complications; laser treatment can cause temporary vision changes or, in some cases, mild permanent peripheral vision loss as an intended trade-off for reducing risk of more severe bleeding; and vitrectomy surgery carries risks similar to other intraocular surgery, including infection, bleeding, and retinal detachment. Because diabetic retinopathy risk correlates closely with blood sugar and blood pressure control, the clinic's approach generally emphasizes coordination between eye-specific treatment and a patient's broader diabetes management.
Diabetic Retinopathy During Pregnancy
Pregnancy is specifically recognized as a risk factor that can accelerate diabetic retinopathy progression, both in women with pre-existing diabetes and in some cases of gestational diabetes. Hormonal and metabolic changes during pregnancy can cause retinopathy that was previously stable to worsen relatively quickly, which is why pregnant patients with diabetes are generally advised to have a dilated eye exam early in pregnancy, with follow-up exams scheduled more frequently than the standard annual interval throughout the pregnancy and sometimes into the postpartum period. Because some treatments used for diabetic retinopathy, including certain anti-VEGF injections, require careful consideration during pregnancy, management decisions in this context are generally made in close coordination between the ophthalmologist and the patient's obstetric care team.
Comparing Diabetic Retinopathy Treatment Approaches
| Approach | Typical Use | Considerations |
|---|---|---|
| Observation with regular monitoring | Early or mild non-proliferative disease | No procedure required; relies on consistent follow-up |
| Anti-VEGF injections | Macular edema or proliferative disease | Often requires repeated injections over months |
| Laser photocoagulation | Leaking vessels or proliferative disease | Outpatient, topical/local anesthesia |
| Vitrectomy surgery | Advanced disease with bleeding or detachment risk | More involved recovery; reserved for advanced cases |
Alternative and complementary measures include tighter blood sugar, blood pressure, and cholesterol control, which do not replace eye-specific treatment but can influence how quickly the condition progresses over time.
Combining Diabetic Retinopathy Care with Other Treatments

Diabetic retinopathy screening and monitoring is frequently combined with glaucoma evaluation and general retinal assessment during the same comprehensive eye exam, since much of the same imaging — OCT, fundus photography, and AI-assisted analysis — is relevant across these overlapping conditions.
Patients newly diagnosed with diabetic retinopathy sometimes focus entirely on the eye-specific treatment while overlooking that blood sugar and blood pressure control at the systemic level remain central to slowing disease progression; the clinic's ophthalmologists generally address both dimensions during counseling rather than treating the eye in isolation from the underlying diabetes.
The Bottom Line
Diabetic retinopathy damages retinal blood vessels due to chronically elevated blood sugar and is a leading cause of vision loss among adults with diabetes.
Early stages often cause no symptoms, which is why regular dilated eye exams are recommended for all patients with diabetes.
Treatment ranges from monitoring to anti-VEGF injections, laser treatment, and vitrectomy surgery, depending on disease stage and severity.
Diabetic macular edema, a swelling of the retina's central region, can occur at any stage and is a common cause of vision loss.
Dr. Kim Yoon Kyung's academic research specifically addresses diabetic retinopathy with vitreous hemorrhage, directly relevant to this condition.
Frequently Asked Questions
Can diabetic retinopathy be reversed? Generally, retinal damage already present cannot be fully reversed, though treatment can reduce swelling, slow abnormal blood vessel growth, and help preserve remaining vision. This is why early detection through regular dilated eye exams matters, since it allows treatment before more extensive damage occurs.
How often should I get my eyes checked if I have diabetes? This depends on your current retinopathy status; patients with no or mild disease are often advised to have an annual dilated eye exam, while those with more advanced disease or active treatment such as injections may need much more frequent monitoring, sometimes monthly.
Does better blood sugar control help my eyes even after diabetic retinopathy is diagnosed? Yes — blood sugar, blood pressure, and cholesterol control can influence how quickly diabetic retinopathy progresses, even after a diagnosis, which is why systemic diabetes management remains an important complement to eye-specific treatment.
What is diabetic macular edema, and how is it different from diabetic retinopathy generally? Diabetic macular edema is swelling of the macula, the retina's central region responsible for sharp vision, caused by fluid leakage; it can occur at any stage of diabetic retinopathy and is one of the more common causes of vision loss associated with the broader condition.
Are anti-VEGF injections painful, and how often are they needed? Injections are typically performed with topical or local anesthesia to minimize discomfort, and the required frequency depends on the specific condition being treated — often more frequent initially, then potentially spaced out as the condition stabilizes with treatment.
Book a Consultation at Jamsil Samsung Eye Clinic

To schedule a diabetic retinopathy screening or discuss treatment options, contact Jamsil Samsung Eye Clinic in Songpa-gu, Seoul, through its online consultation and contact page or by phone at +82-2-424-7523.
Disclaimer
This page is for general informational purposes and does not constitute individualized medical advice. Diagnosis and treatment recommendations can only be determined through evaluation by a qualified physician.
Sources & Further Reading
Other Services
Explore additional ophthalmology treatments offered by our specialists.
EVO AQUA ICL (Implantable Collamer Lens)
EVO AQUA ICL is a vision-correction procedure in which a specialized corrective lens made of biocompatible Collamer material is inserted directly between the natural lens and the iris, without damaging or reshaping the cornea.
Learn More
Presbyopia Surgery (Clareon PanOptix Pro)
Presbyopia surgery with the Clareon PanOptix Pro trifocal lens corrects presbyopia — the age-related loss of near-focusing ability caused by the eye's lens stiffening and losing elasticity, combined with reduced ciliary-muscle function — by implanting a
Learn More
Presbyopia Precision Exam Program
The Presbyopia Precision Exam Program is a specialized diagnostic evaluation designed to thoroughly measure eye health, corneal state, and refractive index before prescribing presbyopia correction or laser vision procedures.
Learn More